Published in Pacing Clin Electrophysiol on October 01, 2009
Behavioral interventions in patients with an implantable cardioverter defibrillator: lessons learned and where to go from here? Pacing Clin Electrophysiol (2013) 0.85
Nurse-Enhanced Memory Intervention in Heart Failure: the MEMOIR study. J Card Fail (2011) 0.83
Sleep quality and sleepiness in persons with implantable cardioverter defibrillators: outcome from a clinical randomized longitudinal trial. Pacing Clin Electrophysiol (2012) 0.79
COPE-ICD: a randomised clinical trial studying the effects and meaning of a comprehensive rehabilitation programme for ICD recipients -design, intervention and population. BMC Cardiovasc Disord (2011) 0.78
A prospective study of anxiety in ICD patients with a pilot randomized controlled trial of cognitive behavioral therapy for patients with moderate to severe anxiety. J Interv Card Electrophysiol (2015) 0.76
Effective communication and ethical consent in decisions related to ICDs. Nat Rev Cardiol (2011) 0.75
The Challenges of Living With an Implantable Cardioverter Defibrillator: A Qualitative Study. Iran Red Crescent Med J (2016) 0.75
A pilot study of a mindfulness based stress reduction program in adolescents with implantable cardioverter defibrillators or pacemakers. Pediatr Cardiol (2014) 0.75
Group therapy with patients suffering from medical illnesses. Int J Group Psychother (2011) 0.75
Depression and Associated Factors in Patients with Implantable Cardioverter-Defibrillators. J Tehran Heart Cent (2016) 0.75
A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis (1987) 174.79
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med (2002) 27.55
Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med (2005) 27.36
A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J Am Geriatr Soc (1975) 21.45
A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index). Am J Cardiol (1989) 5.50
Quality of life with defibrillator therapy or amiodarone in heart failure. N Engl J Med (2008) 4.33
Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator. Circulation (2004) 3.03
The effects of age on quality of life in implantable cardioverter defibrillator recipients. J Clin Nurs (2004) 2.61
Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials. JAMA (2004) 2.44
Quality of life in the antiarrhythmics versus implantable defibrillators trial: impact of therapy and influence of adverse symptoms and defibrillator shocks. Circulation (2002) 2.16
Emotional and physical precipitants of ventricular arrhythmia. Circulation (2002) 2.09
Prophylactic implantable cardioverter-defibrillator therapy in patients with left ventricular systolic dysfunction: a pooled analysis of 10 primary prevention trials. J Am Coll Cardiol (2004) 2.03
A comprehensive management system for heart failure improves clinical outcomes and reduces medical resource utilization. Am J Cardiol (1997) 1.75
Implantable cardioverter defibrillator recipients: quality of life in recipients with and without ICD shock delivery: a prospective study. Europace (2003) 1.61
Quality of life and psychological functioning of icd patients. Heart (2002) 1.61
Depression and anxiety symptoms are associated with reduced dietary adherence in heart failure patients treated with an implantable cardioverter defibrillator. J Cardiovasc Nurs (2008) 1.56
Short-term efficacy of a telephone intervention by expert nurses after an implantable cardioverter defibrillator. Pacing Clin Electrophysiol (2004) 1.52
Examining the psychosocial impact of implantable cardioverter defibrillators: a literature review. Clin Cardiol (1999) 1.51
Depression as a predictor for appropriate shocks among patients with implantable cardioverter-defibrillators: results from the Triggers of Ventricular Arrhythmias (TOVA) study. J Am Coll Cardiol (2005) 1.50
Relation of clinical and angiographic factors to functional capacity as measured by the Duke Activity Status Index. Am J Cardiol (1991) 1.48
The high cost of implantable defibrillators. Eur Heart J (2006) 1.37
Posttraumatic stress symptoms and predicted mortality in patients with implantable cardioverter-defibrillators: results from the prospective living with an implanted cardioverter-defibrillator study. Arch Gen Psychiatry (2008) 1.37
Moderate exercise training improves functional capacity, quality of life, and endothelium-dependent vasodilation in chronic heart failure patients with implantable cardioverter defibrillators and cardiac resynchronization therapy. Eur J Cardiovasc Prev Rehabil (2006) 1.27
Systematic review: implantable cardioverter defibrillators for adults with left ventricular systolic dysfunction. Ann Intern Med (2007) 1.21
Destabilizing effects of mental stress on ventricular arrhythmias in patients with implantable cardioverter-defibrillators. Circulation (2000) 1.21
Quality-of-life in patients receiving implantable cardioverter defibrillators at or before age 40. Pacing Clin Electrophysiol (1996) 1.14
The effect of psychological intervention on patients' long-term adjustment to the ICD: a prospective study. Pacing Clin Electrophysiol (2000) 1.14
Patient acceptance of the implantable cardioverter defibrillator in ventricular tachyarrhythmias. Pacing Clin Electrophysiol (1993) 1.13
Association of mood disturbance and arrhythmia events in patients after cardioverter defibrillator implantation. Depress Anxiety (1999) 1.12
Patients' attitudes toward implanted defibrillator shocks. Pacing Clin Electrophysiol (2000) 1.12
Randomized trial of a psychologic distress screening program after breast cancer: effects on quality of life. J Clin Oncol (1996) 1.12
The ICD shock and stress management program: a randomized trial of psychosocial treatment to optimize quality of life in ICD patients. Pacing Clin Electrophysiol (2007) 1.10
Long-term outcomes of a telephone intervention after an ICD. Pacing Clin Electrophysiol (2005) 1.02
Psychological intervention following implantation of an implantable defibrillator: a review and future recommendations. Pacing Clin Electrophysiol (2007) 1.02
Psychosocial issues of patients with implantable cardioverter defibrillators. Am J Crit Care (2005) 0.99
Internal cardioverter defibrillator device discharge: experiences of patients and family members. Heart Lung (1994) 0.98
Concerns about the implantable cardioverter defibrillator: a determinant of anxiety and depressive symptoms independent of experienced shocks. Am Heart J (2005) 0.96
Quality of life in implanted cardioverter defibrillator recipients: the impact of a device shock. Heart Lung (2005) 0.94
Measurement of patient fears about implantable cardioverter defibrillator shock: an initial evaluation of the Florida Shock Anxiety Scale. Pacing Clin Electrophysiol (2006) 0.94
Young at heart: understanding the unique psychosocial adjustment of young implantable cardioverter defibrillator recipients. Pacing Clin Electrophysiol (2001) 0.93
Longitudinal recovery following sudden cardiac arrest and internal cardioverter defibrillator implantation: survivors and their families. Am J Crit Care (1994) 0.92
Costs and quality-of-life effects of implantable cardioverter-defibrillators. Am J Cardiol (2006) 0.91
Quality of life in younger persons with an implantable cardioverter defibrillator. Dimens Crit Care Nurs (1995) 0.91
Age-specific differences in women with implantable cardioverter defibrillators: an international multi center study. Pacing Clin Electrophysiol (2008) 0.90
The effect of psychosocial nursing intervention on the mood state of patients with implantable cardioverter defibrillators and their caregivers. Prog Cardiovasc Nurs (1997) 0.89
The psychosocial effects of support group intervention on AICD recipients and their significant others. Prog Cardiovasc Nurs (1994) 0.87
Measuring patient acceptance of implantable cardiac device therapy: initial psychometric investigation of the Florida Patient Acceptance Survey. J Cardiovasc Electrophysiol (2005) 0.86
Resource loss predicts depression and anxiety among patients treated with an implantable cardioverter defibrillator. Psychosom Med (2006) 0.84
Women and the implantable cardioverter defibrillator: a lifespan perspective on key psychosocial issues. Clin Cardiol (2004) 0.84
Educational intervention for patients with automatic implantable cardioverter defibrillators. Aust J Adv Nurs (2007) 0.83
Life after sudden death: the development of a support group for automatic implantable cardioverter-defibrillator patients. J Cardiovasc Nurs (1990) 0.82
Patients with implantable cardioverter-defibrillators and their conceptions of the life situation: a qualitative analysis. J Clin Nurs (2000) 0.81
Social support, anxiety, and support group participation in patients with an implantable cardioverter defibrillator. Prog Cardiovasc Nurs (2008) 0.80
Factors associated with outcomes 3 months after implantable cardioverter defibrillator insertion. Heart Lung (1999) 0.79
A CNS-facilitated ICD support group: a clinical project evaluation. Clin Nurse Spec (2006) 0.78
Benefits of cardiac rehabilitation in patients with implantable cardioverter-defibrillators: a patient survey. Arch Phys Med Rehabil (2005) 0.78
Implantable cardioverter defibrillators: physical and psychosocial outcomes. Am J Crit Care (1997) 0.78
Increased emotional distress in type-D cardiac patients without a partner. J Psychosom Res (2007) 0.77
Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med (2007) 25.17
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2010) 7.54
Glucose-independent, black-white differences in hemoglobin A1c levels: a cross-sectional analysis of 2 studies. Ann Intern Med (2010) 4.87
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation (2010) 4.56
ACCF 2012 expert consensus document on practical clinical considerations in the interpretation of troponin elevations: a report of the American College of Cardiology Foundation task force on Clinical Expert Consensus Documents. J Am Coll Cardiol (2012) 4.45
Pacing features that mimic malfunction: a review of current programmable and automated device functions that cause confusion in the clinical setting. J Cardiovasc Electrophysiol (2009) 4.19
Body and soul. A dietary intervention conducted through African-American churches. Am J Prev Med (2004) 3.83
The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromes. Ann Intern Med (2004) 3.78
Off-pump vs conventional coronary artery bypass grafting: early and 1-year graft patency, cost, and quality-of-life outcomes: a randomized trial. JAMA (2004) 3.48
Monitoring clinical changes in patients with heart failure: a comparison of methods. Am Heart J (2005) 3.26
Obstructive coronary atherosclerosis and ischemic heart disease: an elusive link! J Am Coll Cardiol (2012) 2.93
Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry. Circulation (2010) 2.93
Treatments, trends, and outcomes of acute myocardial infarction and percutaneous coronary intervention. J Am Coll Cardiol (2010) 2.86
Lipid-lowering drug use is associated with reduced prevalence of atrial fibrillation in patients with left ventricular systolic dysfunction. Heart Rhythm (2006) 2.81
Hands-on defibrillation: an analysis of electrical current flow through rescuers in direct contact with patients during biphasic external defibrillation. Circulation (2008) 2.80
Patient adherence improves glycemic control. Diabetes Educ (2005) 2.69
Predictors of long-term survival after coronary artery bypass grafting surgery: results from the Society of Thoracic Surgeons Adult Cardiac Surgery Database (the ASCERT study). Circulation (2012) 2.54
Impact of ethnicity and gender differences on angiographic coronary artery disease prevalence and in-hospital mortality in the American College of Cardiology-National Cardiovascular Data Registry. Circulation (2008) 2.53
Contemporary mortality risk prediction for percutaneous coronary intervention: results from 588,398 procedures in the National Cardiovascular Data Registry. J Am Coll Cardiol (2010) 2.49
Outcomes and long-term survival for patients undergoing mitral valve repair versus replacement: effect of age and concomitant coronary artery bypass grafting. Circulation (2003) 2.45
Long-term follow-up of coronary artery disease presenting in young adults. J Am Coll Cardiol (2003) 2.30
The frequency and cost of complications associated with coronary artery bypass grafting surgery: results from the United States Medicare program. Ann Thorac Surg (2008) 2.29
Prevalence and outcomes of same-day discharge after elective percutaneous coronary intervention among older patients. JAMA (2011) 2.29
Downregulation of endocardial nitric oxide synthase expression and nitric oxide production in atrial fibrillation: potential mechanisms for atrial thrombosis and stroke. Circulation (2002) 2.22
Value of primordial and primary prevention for cardiovascular disease: a policy statement from the American Heart Association. Circulation (2011) 2.08
Results of the healthy body healthy spirit trial. Health Psychol (2005) 2.07
The frequency and incremental cost of major complications among medicare beneficiaries receiving implantable cardioverter-defibrillators. J Am Coll Cardiol (2006) 2.05
Chronic kidney disease, anemia, and incident stroke in a middle-aged, community-based population: the ARIC Study. Kidney Int (2003) 2.04
Association between novel oxidative stress markers and C-reactive protein among adults without clinical coronary heart disease. Atherosclerosis (2005) 2.02
Health status identifies heart failure outpatients at risk for hospitalization or death. J Am Coll Cardiol (2006) 1.98
Understanding the pathophysiology of apical ballooning syndrome: a step closer. Expert Rev Cardiovasc Ther (2014) 1.97
Using motivational interviewing to promote adherence to antiretroviral medications: a pilot study. J Assoc Nurses AIDS Care (2003) 1.87
Low levels of high-density lipoprotein cholesterol and increased risk of cardiovascular events in stable ischemic heart disease patients: A post-hoc analysis from the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation). J Am Coll Cardiol (2013) 1.86
Annual direct and indirect health care costs of chronic idiopathic urticaria: a cost analysis of 50 nonimmunosuppressed patients. Arch Dermatol (2008) 1.85
Sex differences in hospital mortality after coronary artery bypass surgery: evidence for a higher mortality in younger women. Circulation (2002) 1.85
Baseline stress myocardial perfusion imaging results and outcomes in patients with stable ischemic heart disease randomized to optimal medical therapy with or without percutaneous coronary intervention. Am Heart J (2012) 1.84
Trends in utilization and complications of catheter ablation for atrial fibrillation in Medicare beneficiaries. Heart Rhythm (2009) 1.82
Patient health status and costs in heart failure: insights from the eplerenone post-acute myocardial infarction heart failure efficacy and survival study (EPHESUS). Circulation (2009) 1.82
Results of go girls: a weight control program for overweight African-American adolescent females. Obes Res (2005) 1.77
Trials and tribulations of non-inferiority: the ximelagatran experience. J Am Coll Cardiol (2005) 1.75
Neuropsychological outcome after percutaneous coronary intervention or coronary artery bypass grafting: results from the Stent or Surgery (SoS) Trial. Circulation (2004) 1.73
Coronary stent restenosis in patients treated with cilostazol. Circulation (2005) 1.73
Diagnosing and managing cutaneous pigmented lesions: primary care physicians versus dermatologists. J Gen Intern Med (2006) 1.65
Prognostic value of health status in patients with heart failure after acute myocardial infarction. Circulation (2004) 1.63
Impact of race and gender on cardiac device implantations. Heart Rhythm (2007) 1.62
The relationship between plasma levels of oxidized and reduced thiols and early atherosclerosis in healthy adults. J Am Coll Cardiol (2006) 1.59
Impact of metabolic syndrome and diabetes on prognosis and outcomes with early percutaneous coronary intervention in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) trial. J Am Coll Cardiol (2011) 1.58
The relationship between B-type natriuretic peptide and health status in patients with heart failure. J Card Fail (2005) 1.58
Family education and support interventions in heart failure: a pilot study. Nurs Res (2005) 1.58
Angiographic disease progression and residual risk of cardiovascular events while on optimal medical therapy: observations from the COURAGE Trial. Circ Cardiovasc Interv (2011) 1.56
A contemporary overview of percutaneous coronary interventions. The American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR). J Am Coll Cardiol (2002) 1.54
Predicting cardiovascular events with coronary calcium scoring. N Engl J Med (2008) 1.53
Validity of a modified CHAMPS physical activity questionnaire among African-Americans. Med Sci Sports Exerc (2003) 1.52
Economic analysis of a transesophageal echocardiography-guided approach to cardioversion of patients with atrial fibrillation: the ACUTE economic data at eight weeks. J Am Coll Cardiol (2004) 1.52
The relationship of bipolar left ventricular pacing stimulus intensity to cardiac depolarization and repolarization in humans with cardiac resynchronization devices. J Cardiovasc Electrophysiol (2009) 1.51
The evolving pattern of symptomatic coronary artery disease in the United States and Canada: baseline characteristics of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial. Am J Cardiol (2006) 1.47
Determining the in-hospital cost of bleeding in patients undergoing percutaneous coronary intervention. J Interv Cardiol (2009) 1.47
Risk of local adverse events following cardiac catheterization by hemostasis device use and gender. J Invasive Cardiol (2004) 1.47
Depressive symptoms after acute myocardial infarction: evidence for highest rates in younger women. Arch Intern Med (2006) 1.47
Relationship between procedure indications and outcomes of percutaneous coronary interventions by American College of Cardiology/American Heart Association Task Force Guidelines. Circulation (2005) 1.47
Association of high serum creatinine and anemia increases the risk of coronary events: results from the prospective community-based atherosclerosis risk in communities (ARIC) study. J Am Soc Nephrol (2003) 1.47
Adherence to antiretroviral medication regimens: a test of a psychosocial model. AIDS Behav (2007) 1.45
Economic outcome of cardiac CT-based evaluation and standard of care for suspected acute coronary syndrome in the emergency department: a decision analytic model. Acad Radiol (2011) 1.45
Long-term follow-up of polytetrafluoroethylene-covered stents implanted during percutaneous coronary intervention for management of acute coronary perforation. Catheter Cardiovasc Interv (2011) 1.44
Prognostic implication of creatine kinase release after elective percutaneous coronary intervention in the pre-IIb/IIIa antagonist era. Am Heart J (2003) 1.44
Quantitative results of baseline angiography and percutaneous coronary intervention in the COURAGE trial. Circ Cardiovasc Qual Outcomes (2009) 1.43
Many Americans have pre-diabetes and should be considered for metformin therapy. Diabetes Care (2009) 1.43
The influence of diabetes mellitus on the practice and outcomes of percutaneous coronary intervention in the community: a report from the HCA database. J Invasive Cardiol (2003) 1.43
Linking the National Cardiovascular Data Registry CathPCI Registry with Medicare claims data: validation of a longitudinal cohort of elderly patients undergoing cardiac catheterization. Circ Cardiovasc Qual Outcomes (2012) 1.42
A longitudinal assessment of coronary interventional program quality: a report from the American College of Cardiology-National Cardiovascular Data Registry. JACC Cardiovasc Interv (2009) 1.41
Brief report: sexual sensation seeking and its relationship to risky sexual behaviour among African-American adolescent females. J Adolesc (2006) 1.41
Cardiovascular risk factors one year after a hypertensive disorder of pregnancy. J Womens Health (Larchmt) (2014) 1.40
The importance of cardiorespiratory fitness in the United States: the need for a national registry: a policy statement from the American Heart Association. Circulation (2013) 1.37
Development of a risk adjustment mortality model using the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR) experience: 1998-2000. J Am Coll Cardiol (2002) 1.35
Cardiac resynchronization in patients with congestive heart failure and chronic atrial fibrillation: effect of upgrading to biventricular pacing after chronic right ventricular pacing. J Am Coll Cardiol (2002) 1.34
Report of the National Heart, Lung, and Blood Institute working group on outcomes research in cardiovascular disease. Circulation (2005) 1.34
The American Heart Association's principles for comparative effectiveness research: a policy statement from the American Heart Association. Circulation (2009) 1.33
Keepin' it R.E.A.L.!: results of a mother-adolescent HIV prevention program. Nurs Res (2006) 1.33
Time course of depression and outcome of myocardial infarction. Arch Intern Med (2006) 1.30
Random plasma glucose in serendipitous screening for glucose intolerance: screening for impaired glucose tolerance study 2. J Gen Intern Med (2008) 1.28
Depression predicts mortality and hospitalization in patients with myocardial infarction complicated by heart failure. Am Heart J (2005) 1.27
A randomized trial of practice facilitation to improve the delivery of chronic illness care in primary care: initial and sustained effects. Implement Sci (2013) 1.26
Utility estimates for decision-analytic modeling in chronic heart failure--health states based on New York Heart Association classes and number of rehospitalizations. Value Health (2008) 1.24
Identifying heart failure patients at high risk for near-term cardiovascular events with serial health status assessments. Circulation (2007) 1.24
The financial and nonfinancial costs of implementing electronic health records in primary care practices. Health Aff (Millwood) (2011) 1.23
Validity of self-reported sunscreen use by parents, children, and lifeguards. Am J Prev Med (2008) 1.20
Serum vitamin D concentrations are related to depression in young adult US population: the Third National Health and Nutrition Examination Survey. Int Arch Med (2010) 1.20
Excessive daytime sleepiness is associated with poor medication adherence in adults with heart failure. J Card Fail (2010) 1.19
ACCF/AHA 2011 key data elements and definitions of a base cardiovascular vocabulary for electronic health records: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards. J Am Coll Cardiol (2011) 1.19
Lipid-altering efficacy of ezetimibe plus statin and statin monotherapy and identification of factors associated with treatment response: a pooled analysis of over 21,000 subjects from 27 clinical trials. Atherosclerosis (2012) 1.19